2026-2034年全球醫療保健製藥合約開發和生產組織（CDMO）市場規模、佔有率、趨勢和成長分析報告

預計醫療保健合約開發和生產組織 (CDMO) 市場將從 2025 年的 3,574.8 億美元成長到 2034 年的 1.0495 兆美元，2026 年至 2034 年的複合年成長率為 12.17%。

隨著製藥和生物技術公司擴大將藥物研發和生產流程外包，全球醫療保健合約研發生產力組織（CDMO）市場正在迅速擴張。 CDMO提供廣泛的服務，包括製劑開發、臨床試驗樣本生產和大規模生產。這種外包模式使企業能夠降低營運成本、提高效率並加速新治療方法的商業化。

CDMO市場的主要驅動力之一是藥物研發日益複雜化以及對專業化生產能力的需求不斷成長。製藥公司與CDMO合作，以利用現代藥物生產所需的先進技術和法規專業知識。此外，生物製藥和個人化醫療的進步也進一步增加了對專業化生產服務的需求。

未來，隨著藥物研發管線的擴展，CDMO市場預計將顯著成長。生物製造、連續生產製程和先進藥物遞送系統等領域的技術創新將提升產能。此外，隨著全球製藥公司在全球範圍內拓展生產夥伴關係關係，新興市場預計也將在市場成長中發揮重要作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球醫療保健藥品合約開發與生產組織 (CDMO) 市場：按服務分類

• 市場分析、洞察與預測
• 合約開發（小分子、聚合物、衝擊波療法）
• 契約製造（低分子量化合物、高分子量化合物、高活性原料藥、最終製劑、醫療設備）

第5章 全球醫療保健製藥合約開發與生產組織（CDMO）市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第6章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第7章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Catalent Inc
  • Lonza Group Ltd
  • Recipharm AB
  • Siegfried Holding AG
  • Therm Fisher Scientific Inc
  • Covance Inc
  • Jabil
  • Sanmina Corporation
  • IQVIA Holdings Inc
  • Flex

The Healthcare Contract Development and Manufacturing Organization Market size is expected to reach USD 1004.95 Billion in 2034 from USD 357.48 Billion (2025) growing at a CAGR of 12.17% during 2026-2034.

The global healthcare contract development and manufacturing organization (CDMO) market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource drug development and manufacturing processes. CDMOs provide a range of services, including drug formulation, clinical trial material production, and large-scale manufacturing. This outsourcing model helps companies reduce operational costs, improve efficiency, and accelerate the commercialization of new therapies.

One of the primary drivers of the CDMO market is the growing complexity of drug development and the increasing demand for specialized manufacturing capabilities. Pharmaceutical companies are collaborating with CDMOs to access advanced technologies and regulatory expertise required for modern drug production. Additionally, the rising development of biologics and personalized medicines is further driving the need for specialized manufacturing services.

In the future, the CDMO market is expected to grow significantly as pharmaceutical pipelines continue to expand. Technological innovations in biomanufacturing, continuous processing, and advanced drug delivery systems will enhance production capabilities. Emerging markets are also expected to play a crucial role in market growth as global pharmaceutical companies expand their manufacturing partnerships worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Contract Development (Small Molecule, Large Molecule, Shockwave Therapy)
• Contract Manufacturing (Small Molecule, Large Molecule, High Potency API, Finished Dose Formulations, Medical Devices)

COMPANIES PROFILED

• Catalent Inc, Lonza Group Ltd, Recipharm AB, Siegfried Holding AG, Therm Fisher Scientific Inc, Covance Inc, Jabil, Sanmina Corporation, IQVIA Holdings Inc, Flex
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Contract Development (Small Molecule, Large Molecule, Shockwave Therapy) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Contract Manufacturing (Small Molecule, Large Molecule, High Potency API, Finished Dose Formulations, Medical Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 5.1. Regional Outlook
• 5.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.2.1 By Services
  • 5.2.2 United States
  • 5.2.3 Canada
  • 5.2.4 Mexico
• 5.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.3.1 By Services
  • 5.3.2 United Kingdom
  • 5.3.3 France
  • 5.3.4 Germany
  • 5.3.5 Italy
  • 5.3.6 Russia
  • 5.3.7 Rest Of Europe
• 5.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.4.1 By Services
  • 5.4.2 India
  • 5.4.3 Japan
  • 5.4.4 South Korea
  • 5.4.5 Australia
  • 5.4.6 South East Asia
  • 5.4.7 Rest Of Asia Pacific
• 5.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.5.1 By Services
  • 5.5.2 Brazil
  • 5.5.3 Argentina
  • 5.5.4 Peru
  • 5.5.5 Chile
  • 5.5.6 Rest of Latin America
• 5.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.6.1 By Services
  • 5.6.2 Saudi Arabia
  • 5.6.3 UAE
  • 5.6.4 Israel
  • 5.6.5 South Africa
  • 5.6.6 Rest of the Middle East And Africa

Chapter 6. COMPETITIVE LANDSCAPE

• 6.1. Recent Developments
• 6.2. Company Categorization
• 6.3. Supply Chain & Channel Partners (based on availability)
• 6.4. Market Share & Positioning Analysis (based on availability)
• 6.5. Vendor Landscape (based on availability)
• 6.6. Strategy Mapping

Chapter 7. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION INDUSTRY

• 7.1. Top Companies Market Share Analysis
• 7.2. Company Profiles
  • 7.2.1 Catalent Inc
  • 7.2.2 Lonza Group Ltd
  • 7.2.3 Recipharm AB
  • 7.2.4 Siegfried Holding AG
  • 7.2.5 Therm Fisher Scientific Inc
  • 7.2.6 Covance Inc
  • 7.2.7 Jabil
  • 7.2.8 Sanmina Corporation
  • 7.2.9 IQVIA Holdings Inc
  • 7.2.10 Flex